THURSDAY, 3 OCTOBER 2024

Note: All times listed are in Central European Summer Time (CEST)

9:00 AM – 10:50 AM: Preclinical Considerations & Innovations
Room: Queen’s Hall

9:00 AM – 9:30 AM   
Melissa H. Little, Novo Nordish Foundation Centre for Stem Cell Medicine (reNEW), Denmark, and Murdoch Children's Research Institute, Australia
STEM CELL DERIVED KIDNEY TISSUE; THE CHALLENGES OF CLINICAL DELIVERY

9:30 AM – 9:45 AM   
Marcelo Rivolta, University of Sheffield, UK
DEVELOPING A PSC-DERIVED THERAPY FOR HEARING LOSS: PRECLINICAL EFFICACY AND BIOSAFETY OF OTIC NEUROPROGENITOR CELLS

9:45 AM – 10:00 AM   
Beth Cobb, Cincinnati Children's Hospital and Medical Center, USA
MULTIDISCIPLINARY PURSUIT OF GI ORGANOID THERAPY IND

10:00 AM – 10:20 AM  | Innovation Showcase: Thermo Fischer Scientific
Michael L. Akenhead, Thermo Fisher Scientific, USA
STEM CELLS AND 3D: EXPANSION AND UPSCALING

10:20 AM – 10:50 AM
Ludovic Vallier, Berlin Institute of Health, Germany
NEXT GENERATION OF PRECLINICAL MODELS FOR CELL BASED THERAPIES AGAINST LIVER DISEASES

10:50 AM – 11:15 AM: Refreshment Break
Room: Foyer

11:15 AM – 12:15 PM: Regulatory Interactions & Unified Standpoints Panel: Part I
Room: Queen’s Hall

Sponsored by: Burroughs Wellcome Fund

Moderator:
Kapil Bharti, NEI/NIH, USA

Panelists:
Jacqueline Barry, CGT Catapult, UK

Malin Parmar, Lund University, Sweden

Heather Lombardi, OTP, CBER, FDA, USA

Lotte Dahl Nissen, The Danish Medicines Agency, Denmark

Jun Takahashi, Kyoto University & CiRA, Japan

12:15 PM – 1:15 PM: Lunch
ROOM: Foyer

1:15 PM – 2:15 PM: Regulatory Interactions & Unified Standpoints Panel: Part II
Room: Queen’s Hall

Sponsored by: HOYA Consulting

Moderator:
Melissa K. Carpenter, Carpenter Consulting Corporation, USA

Panelists:

Wolfram Zimmermann, University Medical Center Göttingen & Repairon, Germany

Dennis Clegg, Regenerative Patch Technologies & UC Santa Barbara, USA

Masayo Takahashi, Vision Care, Japan

Ana Hidalgo-Simon, reNEW & LUMC, The Netherlands

Rachel Rowbottom, Simon-Kucher, UK

2:15 PM – 2:45 PM: ISSCR Standards Phase II: PSC-Derived Cell Therapies
Room: Queen’s Hall

Jacqueline Barry, CGT Catapult, UK & Kapil Bharti, NEI/NIH, USA
CURRENT BEST PRACTICE FOR THE TRANSLATION OF PSC-BASED THERAPIES - AN UPDATE

2:45 PM – 3:15 PM: Refreshment Break
Room: Foyer

3:15 PM – 5:00 PM: Manufacturing & Automation in Cell Therapy Development
Room: Queen’s Hall

3:15 PM - 3:45 PM
Thomas Hassing Ronøe Carlsen, Cellerator, Denmark
NAVIGATING THE BRIDGE FROM LAB TO CLINIC IN STEM CELL-BASED THERAPIES

3:45 PM - 4:15 PM
Ruchi Sharma, NEI/NIH, USA
GMP MANUFACTURING AND RELEASE ASSAYS FOR INDUCED PLURIPOTENT STEM CELLS DERIVED RETINAL PIGMENT EPITHELIUM “PATCH” FOR AUTOLOGOUS CELL-BASED THERAPY FOR AGE-RELATED MACULAR DEGENERATION

4:15 PM - 4:25 PM  | Innovation Showcase: Cellino Biotech
Marinna Madrid, Cellino Biotech, USA
OPTICAL BIOPROCESSING: AN AI- AND LASER-BASED BIOMANUFACTURING TECHNOLOGY TO SCALE PRODUCTION OF PERSONALIZED IPSC-BASED CELL THERAPIES

4:25 PM - 4:30 PM | Innovation Showcase: NecstGen
Sophia Kolbe, NecstGen, Netherlands
GMP-COMPLIANT MANUFACTURING OF IPSCS AND IPSC-DERIVED CELL THERAPIES

4:30 PM - 4:32 PM | Abstract-Selected Sneak Peak Presentation
Ali Afshar, Mytos, UK
MYTOS IDEM: A FLASK-BASED AUTOMATION PLATFORM, TO MOVE FAST FROM LAB TO MANUFACTURING

4:32 PM - 5:00 PM | Panel Discussion

Moderator:
Jacqueline Barry, CGT Catapult, UK

Panelists:

Thomas Hassing Ronøe Carlsen, Cellerator, Denmark

Ruchi Sharma, NEI/NIH, USA

Marinna Madrid, Cellino Biotech, USA

Sophia Kolbe, NecstGen, Netherlands

Ali Afshar, Mytos, UK

5:00 PM – 6:00 PM: Poster Session III
Room: Foyer